| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,578 |
1,925 |
$322K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
371 |
193 |
$47K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,340 |
4,069 |
$44K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
261 |
249 |
$41K |
| 80053 |
Comprehensive metabolic panel |
813 |
701 |
$37K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
330 |
297 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
1,882 |
1,613 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
775 |
639 |
$21K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
67 |
64 |
$21K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
403 |
381 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
295 |
283 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
220 |
205 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
201 |
164 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
76 |
70 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
38 |
36 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
47 |
13 |
$4K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
65 |
56 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
65 |
56 |
$3K |
| 81001 |
|
195 |
174 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
51 |
48 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
247 |
242 |
$3K |
| A0425 |
Ground mileage, per statute mile |
58 |
36 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
52 |
42 |
$2K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
16 |
12 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
47 |
38 |
$2K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
65 |
56 |
$2K |
| 84145 |
|
33 |
26 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
12 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29 |
26 |
$1K |
| 99152 |
|
27 |
26 |
$1K |
| 86140 |
|
47 |
42 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17 |
16 |
$862.36 |
| 83605 |
|
32 |
29 |
$824.94 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
14 |
$628.30 |
| 77003 |
|
13 |
12 |
$493.24 |
| 90674 |
|
20 |
20 |
$450.45 |
| 84484 |
|
19 |
13 |
$447.44 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
12 |
$416.89 |
| G0008 |
Administration of influenza virus vaccine |
37 |
37 |
$382.45 |
| 83690 |
|
15 |
13 |
$332.64 |
| 87081 |
|
12 |
12 |
$301.95 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$290.40 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
12 |
$285.05 |
| 85027 |
|
12 |
12 |
$210.48 |